International Stem Cell CORP·4

Aug 30, 2:12 PM ET

Stephens Jennifer 4

4 · International Stem Cell CORP · Filed Aug 30, 2017

Insider Transaction Report

Form 4
Period: 2017-08-25
Stephens Jennifer
Acting Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-08-25$1.25/sh+70,000$87,500150,000 total
    Exercise: $1.25Exp: 2027-08-25Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]Upon becoming an officer of the company, the reporting person was awarded stock options. The option vest is 3/36th on initial vesting date (08/25/2017) and 1/36th for each additional full month of continuous service from the initial vesting date.

Documents

1 file
  • 4
    stephens_f4.xmlPrimary

    OWNERSHIP DOCUMENT